Highlights
AMEX: NBY       Novabay Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
1.04   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):3,959,952
4 Weeks Range:0.64 - 1.14
4 Weeks Price Volatility (%):
91.23%
52 Weeks Range:0.24 - 1.94
52 Weeks Price Volatility (%):
53.61%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3300  2978  371  3256 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 AMC 2.817-0.243 
 OBLN 3.98+2.37 
 CLBS 3.96+2.33 
 CTRM 0.311-0.03 
 BNGO 7.81-1.33 
 SNDL 0.696+0.006 
 GEVO 8.451-2.579 
 ADMP 1.25+0.445